Politics Global risk may be low, but experts want more data Finance News Oct 6, 2026 Last week, an employee who worked at a Russian anti-plague institute died, possibly from an unspecified form of… Read More...
Politics Russian lab worker’s suspected plague death leaves some questions Finance News Oct 6, 2026 The unexplained death of a lab technician at a Russian research institute handling plague bacteria has raised… Read More...
Politics Russian lab worker dies amid plague reports — here’s what we know Finance News Oct 5, 2026 A researcher at a Russian anti-plague institute has died of what's been identified as a case of the plague, according… Read More...
Politics Novartis signs $7.8 billion Abogen biotech licensing deal Finance News Oct 2, 2026 Novartis has signed a deal worth up to $7.8 billion, in the latest of a flurry of tie-ups between Big Pharma and… Read More...
Politics Lilly, Novo bet on amylin obesity drugs after GLP-1s Finance News Oct 2, 2026 The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines.Instead, drugmakers are… Read More...
Business Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trial Finance News Sep 30, 2026 Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose of… Read More...
Politics White House chief of staff Susie Wiles says she’s cancer free Finance News Sep 16, 2026 Susie Wiles, White House chief of staff, during an Invest America roundtable in the State Dining Room of the White… Read More...
Politics Record U.S. cyclosporiasis outbreak is over, CDC says Finance News Sep 11, 2026 People shop at a Manhattan grocery store on August 13, 2026, in New York City. Spencer Platt | Getty ImagesThe… Read More...
Politics AstraZeneca COPD drug tozorakimab shows positive late-stage trial results Finance News Sep 8, 2026 AstraZeneca on Tuesday released full results from two successful late-stage trials on its experimental drug for… Read More...
Politics Novartis stock plummets 9% after third trial disappointment in a week Finance News Sep 8, 2026 FILE PHOTO: The logo of Swiss drugmaker Novartis is seen at the company's new cell and gene therapy factory in Stein,… Read More...